Pharmacology of Adjuvant Hormonotherapy in Breast Cancer
Status:
Completed
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
This is a biomedical study of interventional type, multicenter, inter-regional.
Patients with hormono-depending breast cancer, for which an indication of adjuvant
hormonotherapy treatment (according to the current treatments) was retained, will be enrolled
in this study. The main objective is to estimate the correlations between pharmacokinetic and
pharmacogenetic parameters of adjuvant hormonal breast cancer treatment, during the first 3
years.